NUTR
Nusatrip Incorporated
9.00$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.1% | +18.4% | +8.3% | +3.4% | +11.7% | -1.1% | +11.0% | -98.3% | -7.7% | +200.9% | +137.6% | |
| – | +15.2% | +6.5% | +10.0% | +9.9% | +11.7% | +2.8% | +8.9% | -96.3% | -9.4% | +255.7% | +142.4% | |
| – | -36.2% | -34.7% | +97.6% | +70.7% | -24.3% | -25.9% | +47.4% | -74.1% | -67.4% | +1,105.0% | -26.4% | |
| – | -36.2% | -34.7% | +97.6% | +70.7% | -24.3% | -25.9% | +47.4% | -74.1% | -67.4% | +1,105.0% | -26.4% | |
| – | -7.5% | +28.1% | -0.6% | +0.8% | +10.4% | +11.1% | +5.3% | -90.9% | +32.0% | -49.1% | +1,018.0% | |
| – | +37.7% | -1.0% | +15.6% | +7.1% | +17.4% | +2.6% | +7.5% | -100.0% | +37,400.5% | -75.0% | -76.2% | |
| – | +353.5% | +65.8% | +66.6% | +7.2% | +49.3% | +3.2% | +26.8% | – | – | – | – | |
| – | +36.1% | +0.1% | +0.9% | -4.0% | +15.1% | -19.8% | +26.5% | -99.6% | -26.7% | -41.5% | -48.9% | |
| – | +23.7% | +9.7% | +5.5% | -0.8% | +19.7% | -19.9% | +22.3% | -85.8% | -0.1% | +89.8% | -4.7% | |
| – | +151.8% | -56.8% | +4.7% | +5.4% | -0.4% | -5.4% | -1.8% | -57.2% | +1.3% | +95.1% | -4.9% | |
| – | – | – | – | -4.4% | +32.3% | -26.7% | +38.1% | -99.8% | +23.2% | -13.6% | -48.3% | |
| – | -5.6% | +12.0% | +8.0% | +11.6% | +3.8% | -5.7% | -9.5% | -92.2% | -75.4% | +229.1% | +140.6% | |
| – | +13.9% | +9.9% | +9.5% | +5.2% | +8.5% | +7.1% | +7.3% | -101.8% | – | – | – | |
| – | +23.8% | +16.8% | +15.9% | +6.3% | +13.0% | +11.0% | +12.1% | -103.2% | – | – | – | |
| – | -4.0% | -0.2% | -4.3% | -1.3% | -0.1% | -2.1% | -2.6% | +83.0% | +5.6% | -5.3% | -67.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.